However, there is no evidence in the literature indicating a direct role of ROR1 in the epigenetic silencing of tumor suppressors, such as CREB3L1, despite its association with poor prognosis in TNBC and bladder cancer [52,53,54,55,56]. The gene discussed is CREB3L1; the disease is neoplasm.